Loading organizations...
Based in Marrickville, New South Wales, Australia, BioScout develops automated, AI-powered airborne disease tracking technology that analyzes fungal spores and pathogens in real-time for the global agricultural industry. The B2B ag-tech company operates with fewer than 25 employees and generates approximately $2 million AUD in annual recurring revenue through its combined hardware leasing and software analytics subscription model. BioScout previously secured a $3 million AUD Seed funding round led by Artesian, alongside a recent $5 million AUD investment to scale its manufacturing and expand operations into North America. The enterprise also receives strategic backing and research funding from major agricultural organizations including AgriFutures and Hort Innovation to deploy its pre-symptomatic sensors across broadacre farming and viticulture sectors. The company was originally founded in 2017 by co-founders Lewis Collins, Saron Berhane, Henry Brindle, and Josh Wilson.
BioScout has raised $2.1M across 1 funding round.
BioScout has raised $2.1M in total across 1 funding round.
BioScout has raised $2.1M in total across 1 funding round.
BioScout's investors include Uniseed.
BioScout has raised $2.1M across 1 funding round. Most recently, it raised $2.1M Seed in June 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 21, 2022 | $2.1M Seed | — | Uniseed | Announced |
